BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 32831305)

  • 1. Assays for Validating Histone Acetyltransferase Inhibitors.
    Waddell AR; Liao D
    J Vis Exp; 2020 Aug; (162):. PubMed ID: 32831305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of novel inhibitors of histone acetyltransferases.
    Eliseeva ED; Valkov V; Jung M; Jung MO
    Mol Cancer Ther; 2007 Sep; 6(9):2391-8. PubMed ID: 17876038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRG15 activates the cdc2 promoter via histone acetylation in human cells.
    Peña AN; Tominaga K; Pereira-Smith OM
    Exp Cell Res; 2011 Jul; 317(11):1534-40. PubMed ID: 21324423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
    Hutt DM; Roth DM; Marchal C; Bouchecareilh M
    Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of CBP- and P300-induced histone acetylations in vivo using native chromatin.
    McManus KJ; Hendzel MJ
    Mol Cell Biol; 2003 Nov; 23(21):7611-27. PubMed ID: 14560007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity.
    Stimson L; Rowlands MG; Newbatt YM; Smith NF; Raynaud FI; Rogers P; Bavetsias V; Gorsuch S; Jarman M; Bannister A; Kouzarides T; McDonald E; Workman P; Aherne GW
    Mol Cancer Ther; 2005 Oct; 4(10):1521-32. PubMed ID: 16227401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship and antitumor activity of 1,4-pyrazine-containing inhibitors of histone acetyltransferases P300/CBP.
    Nie S; Wu F; Wu J; Li X; Zhou C; Yao Y; Song Y
    Eur J Med Chem; 2022 Jul; 237():114407. PubMed ID: 35512565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule modulators of histone acetyltransferase p300.
    Balasubramanyam K; Swaminathan V; Ranganathan A; Kundu TK
    J Biol Chem; 2003 May; 278(21):19134-40. PubMed ID: 12624111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated level of lysine 9-acetylated histone H3 at the MDR1 promoter in multidrug-resistant cells.
    Toth M; Boros IM; Balint E
    Cancer Sci; 2012 Apr; 103(4):659-69. PubMed ID: 22320423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic acetylation of all lysine-4 trimethylated histone H3 is evolutionarily conserved and mediated by p300/CBP.
    Crump NT; Hazzalin CA; Bowers EM; Alani RM; Cole PA; Mahadevan LC
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7814-9. PubMed ID: 21518915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
    Simon RP; Robaa D; Alhalabi Z; Sippl W; Jung M
    J Med Chem; 2016 Feb; 59(4):1249-70. PubMed ID: 26701186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway.
    Xu LX; Li ZH; Tao YF; Li RH; Fang F; Zhao H; Li G; Li YH; Wang J; Feng X; Pan J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):108. PubMed ID: 25523932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAF1 histone acetyltransferase activity in Sp1 activation of the cyclin D1 promoter.
    Hilton TL; Li Y; Dunphy EL; Wang EH
    Mol Cell Biol; 2005 May; 25(10):4321-32. PubMed ID: 15870300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone acetyltransferase promotes fluoride toxicity in LS8 cells.
    Deng H; Fujiwara N; Cui H; Whitford GM; Bartlett JD; Suzuki M
    Chemosphere; 2020 May; 247():125825. PubMed ID: 31927229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crx activates opsin transcription by recruiting HAT-containing co-activators and promoting histone acetylation.
    Peng GH; Chen S
    Hum Mol Genet; 2007 Oct; 16(20):2433-52. PubMed ID: 17656371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surrogate alcohols and their metabolites modify histone H3 acetylation: involvement of histone acetyl transferase and histone deacetylase.
    Choudhury M; Shukla SD
    Alcohol Clin Exp Res; 2008 May; 32(5):829-39. PubMed ID: 18336638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating epigenetic HAT activity for reinstating acetylation homeostasis: A promising therapeutic strategy for neurological disorders.
    Ganai SA; Banday S; Farooq Z; Altaf M
    Pharmacol Ther; 2016 Oct; 166():106-22. PubMed ID: 27411674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manganese chloride induces histone acetylation changes in neuronal cells: Its role in manganese-induced damage.
    Guo Z; Zhang Z; Wang Q; Zhang J; Wang L; Zhang Q; Li H; Wu S
    Neurotoxicology; 2018 Mar; 65():255-263. PubMed ID: 29155171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP.
    Wang R; He Y; Robinson V; Yang Z; Hessler P; Lasko LM; Lu X; Bhathena A; Lai A; Uziel T; Lam LT
    Mol Cancer Ther; 2018 Dec; 17(12):2543-2550. PubMed ID: 30266801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.